Actavis slaps struggling Vivus with generic threat | PharmaBoardroom
written on 09.05.2014
Tags:
,

Actavis slaps struggling Vivus with generic threat

TAGS: ,

After a botched launch for obesity drug Qsymia, a bitter proxy war, a mass exodus of its directors and management and a continued sales struggle, the last thing Vivus needs is a generic threat. But thanks to Actavis, that's exactly what it's getting.

Latest Report